Outpatient cervical ripening with Foley balloon or mifepristone: Insights into the time taken to reach the active phase of labor
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70468 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Maria Carvalho-Afonso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical School, University of Lisbon, Lisbon, Portugal. Hauptthemen laut MEDLINE: Mifepristone, Cervical Ripening, Labor, Induced. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To estimate the median time elapsed between the start of cervical ripening and the diagnosis of the active phase of labor, according to maternal and pregnancy characteristics, in low‐risk pregnancies submitted to outpatient cervical ripening with a Foley balloon catheter or oral mifepristone.
Methods
This was a secondary analysis of a randomized controlled trial conducted in a European tertiary level hospital, including 101 women with singleton pregnancies, cephalic presentation, and an unfavorable Bishop score. Participants were randomized to receive an intracervical Foley balloon catheter or oral mifepristone (200 mg). The main outcome evaluated was the median time elapsed between the start of the cervical ripening process and the active phase of labor. Cox proportional hazards regression was used to estimate hazard ratios (HR) for factors influencing progression to active labor.
Results
The median interval from the start of cervical ripening to the active phase of labor was 34.3 h (interquartile range [IQR]: 25–50.1). Previous pregnancy (HR: 1.74; 95% CI: 1.18–2.58), gestational age (HR: 1.34; 95% CI: 1.04–1.73), and a permeable cervix at baseline (HR: 2.28; 95% CI: 1.44–3.63) were significantly associated with progression to the active phase of labor. Foley balloon and mifepristone showed comparable median times to the active phase of labor, whereas much shorter durations were observed in those with a permeable cervix at baseline.
Conclusion
Maternal age, gestational age, parity, and permeable cervix at baseline significantly influence the time interval from the start of cervical ripening to the active phase of labor. These may constitute a useful set of information for individualized patient counseling, allowing better alignment of expectations and increased satisfaction with the induction process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Medical School, University of Lisbon, Lisbon, Portugal.
- Department of Obstetrics and Gynecology, Santa Maria University Hospital, Lisbon, Portugal.
- CEAUL-Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
- Department of Obstetrics and Gynecology, Hospital Garcia da Orta, Almada, Portugal.
ORCID-Profile: Maria Carvalho-Afonso, Marília Antunes, Diogo Ayres-de-Campos
Zitieren
APA
Carvalho-Afonso, M., Antunes, M., Fonseca, A., & Ayres-de-Campos, D. (2026). Outpatient cervical ripening with Foley balloon or mifepristone: Insights into the time taken to reach the active phase of labor. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70468
Vancouver
Carvalho-Afonso M, Antunes M, Fonseca A, Ayres-de-Campos D. Outpatient cervical ripening with Foley balloon or mifepristone: Insights into the time taken to reach the active phase of labor. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70468
BibTeX
@article{CarvalhoAfonso2026,
author = {Carvalho-Afonso, Maria and Antunes, Marília and Fonseca, Andreia and Ayres-de-Campos, Diogo},
title = {Outpatient cervical ripening with Foley balloon or mifepristone: Insights into the time taken to reach the active phase of labor},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70468}
}
EUVIMED